M ore people die each year from tuberculosis than from any other infectious disease. The bacterium Mycobacterium tuberculosis is transmitted between people by aerosol droplets generated by someone with active lung disease. The immune response prevents disease in most infected people, but the bacteria often persist as an asymptomatic (latent) infection. Many studies have found that the process of autophagy, through which cellular components are broken down and recycled, contributes to the killing of M. tuberculosis. In this issue, Kimmey et al. 1 (page 565) present evidence supporting the previous finding that the autophagy gene Atg5 plays a key part in the host response to M. tuberculosis infection, but they show that loss of many other autophagy genes does not significantly influence disease outcome. These results suggest that Atg5 is essential for restricting M. tuberculosis growth, but that the conventional autophagy pathway is not.
M. tuberculosis is an intracellular pathogen that infects, persists and replicates in immune cells called macrophages (Fig. 1) . These cells are an inhospitable environment for bacteria: engulfment of the bacterium into a membrane-bound compartment known as a phagosome triggers a series of events that leads to the pathogen's destruction in another organelle, the lysosome, in which hydrolytic enzymes break down material targeted for degradation. But M. tuberculosis has evolved to survive this engulfment by preventing phago somal acidification and phagosome and lysosome fusion.
Some people are inherently resistant to infection despite repeated exposure to M. tuber culosis. This suggests that cells of the innate immune system, to which macrophages belong, may kill the bacteria. A role for innate immunity in antituberculosis responses is supported by the finding that human macro phages express pattern-recognition receptors on their surface that are triggered by M. tuberculosis T cells produce cytokines and other effector molecules when the cells recognize infected macro phages. One such cytokine is interferon-γ (IFNγ), which is essential for host resistance against mycobacterial infection in animal models and people. IFNγ profoundly alters gene expression in infected macrophages; in mouse macrophages, it stimulates the production of nitric oxide, which is toxic to M. tuberculosis. This cytokine also promotes phagosomal acidification and phagosomelysosome fusion, presumably by overriding the block imposed by M. tuberculosis, although the molecular details of this process are unclear. What does seem clear, however, is that the antibacterial activities induced by both innate and adaptive immune signals require the induction of autophagy 4, 5 . These data raised the possibility that autophagy is the common pathway used by macrophages to restrict the intracellular growth of M. tuberculosis.
Autophagy is a fundamental process by which cytoplasmic components, including organelles, are delivered to the lysosome for degradation. This occurs by the formation of a double-membrane vesicle, known as the autophagosome, around the cytoplasmic components being targeted. Alongside its role in cellular homeostasis, autophagy is increasingly found to be involved in host defence. For example, two stimuli known to activate autophagy -starvation and treatment with the drug rapamycin -reduce the viability of M. tuberculosis in infected macrophages in vitro 6 . To investigate these obser vations in vivo, researchers turned to mouse This coloured scanning electron micrograph shows a macrophage cell engulfing Mycobacterium tuberculosis cells (pink) by phagocytosis. This process triggers intracellular events leading to bacterial destruction, but some bacteria successfully survive and replicate within the macrophage. It has been suggested that autophagy, a process normally used for degradation and recycling of cellular components, is involved in the immune response against M. tuberculosis, but Kimmey et al. 1 suggest that the conventional autophagy pathway is not essential for this response in vivo. . A separate study in which these mutant mice were infected with a more virulent M. tuberculosis strain found a higher level of bacteria in the lungs than in infected normal mice, and faster death from the infection 8 . This study also found necrotic lung lesions and increased levels of inflammatory cytokines in the mice lacking Atg5 in macrophages. These findings led to the proposal that the ATG5 protein and the autophagy pathway are essential for M. tuberculosis control in vivo.
Kimmey et al. tested this idea using mice that lacked other genetic components required for autophagy in myeloid-lineage cells: Atg3, Atg7, Atg12, Atg14l and Atg16l1. Surprisingly, the authors did not observe the same characteristics when the mice were infected with M. tuberculosis. These data suggest at least two possibilities. One is that ATG5 regulates an autophagy program that does not depend on the other five Atg genes tested. Although there is some evidence for the existence of alternative autophagy pathways 9, 10 , these pathways depend on the function of multiple Atg genes, and additional data in Kimmey and colleagues' study do not support this conclusion.
An alternative possibility is that ATG5 functions in non-autophagic processes that contribute to M. tuberculosis control. Atg genes have been implicated in other vesicletrafficking processes, including endocytosis, protein secretion and LC3-associated phagocytosis [11] [12] [13] . ATG5 interacts with many proteins 14 that could influence pathogenesis, although these proteins are poorly characterized. ATG5 has also been implicated in the regulation of cell death by its association with the proteins Bcl-xL and FADD 15, 16 . Cell death has been linked to inflammation and infection through the recruitment of immune cells, so it is possible that this is the pathway by which ATG5 regulates infection in an autophagyindependent manner.
An intense spotlight has been shining on autophagy as a possible route to designing better vaccines and drugs against M. tuberculosis infection. Although Kimmey and colleagues' findings do not mean that the 'reset' button should be hit on such investigations, further studies are needed to determine whether ATG5 influences M. tuberculosis infection through a non-canonical autophagy pathway or through a different cellular process. Once this is established, researchers will be better positioned to develop strategies for the treatment and prevention of tuberculosis. ■ 
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Silicon chips lighten up
Microprocessor communications have received a boost from the integration of electronics and photonics in silicon -a first step towards low power consumption and efficient computing systems. See Letter p.534 L A U R E N T V I V I E N E ver since the demonstration of the first microprocessor, 'smaller, cheaper, faster' has been the motto of the microelectronics evolution that enables ever-moredensely packed circuits to speed up computer performance. But a bottleneck now exists in terms of speed and power consumption for on-chip data communications; for instance, conventional wires lose energy and reduce the communication speed. A full transition to optical-link technology using photons would overcome these limitations, because photonic devices have no speed constraints and use less energy than conventional electronics 1 . Because silicon is the main material for complementary-metal-oxide-semiconductor (CMOS) technology, which is widely used by the electronics industry, it has been the subject of intense research in photonics, giving rise to what has been called the silicon photonics age 2 . Using the same mat erial for electronics and photonics in a single circuit could increase performance and reduce the power consumption of integrated chips. On page 534 of this issue, Sun and co-workers 3 report a big advance in such efforts: a microprocessor that communicates using light.
Despite the growing interest in silicon photonics and the development of efficient integrated devices (circuits) on silicon-oninsulator (SOI) wafers, only a few complete electronic-photonic circuits have been demonstrated. This is because the silicon substrate for photonics is very different from the standard substrates used in electronicsand even slight changes to CMOS technology can degrade the performance of the transistors used in microchips. As such, developing a process to merge electronics and photonics on a single chip is highly challenging 4, 5 . The first reported strategy for electronicphotonic integration used the 'front-end' approach 6 , in which transistors and photonic devices are placed on the same layer of a silicon chip. The chosen method of fabricating such chips was based on a custom CMOS electronic process on a non-standard SOI substrate, and enables high-speed light propagation on the chips.
But even if this integration solution was reliable for producing efficient on-chip transceivers for data input and output, developing a more complex on-chip system using stateof-the-art electronics would require large investments of money and technologicalprocess development. Furthermore, the main proposed integration solutions would involve a multichip approach 2 in which the photonic and electronic circuits are fabricated independently using different processes, optimized
